[February 15, 2017] |
|
Gingivitis Pipeline Insights, 2017 - Research and Markets
Research and Markets has announced the addition of the "Gingivitis
- Pipeline Insights, 2017" drug pipelines to their offering.
Gingivitis - Pipeline Insights, 2017 provides in depth insights on the
pipeline drugs and their development activities around the Gingivitis.
This report covers the product profiles in various stages of development
including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and
Preregistration.
Report covers the product clinical trials information and other
development activities including technology, licensing, collaborations,
acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.
This report also provides detailed information on the discontinued and
dormant drugs that have gone inactive over the years for Gingivitis.
This report also assesses the Gingivitis therapeutics by Monotherapy,
Combination products, Molecule type and Route of Administration.
Scope:
The report provides competitive pipeline landscape of Gingivitis
The report provides pipeline products under drug profile section which
includes product description, MOA, licensors & collaborators,
development partner and chemical information
Coverage of the Gingivitis pipeline on the basis of target, MOA, route
of administration, technology involved and molecule type
The report reviews key players involved in the therapeutics
development for Gingivitis and also provide company profiling
The report also gives the information of dormant and discontinued
pipeline projects
Pipeline products coverage based on various stages of development
ranging from preregistration till discovery and undisclosed stages
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development and molecule type
Key Topics Covered:
-
Gingivitis Overview
-
Gingivitis Pipeline Therapeutics
-
Gingivitis Therapeutics under Development by Companies
-
Gingivitis Filed and Phase III Products
-
Gingivitis Phase II Products
-
Gingivitis Phase I and IND Filed Products
-
Gingivitis Discovery and Pre-Clinical Stage Products
-
Drug Candidate Profiles
-
Gingivitis - Therapeutics Assessment
-
Companies Involved in Therapeutics Development for Gingivitis
-
Appendix
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/pl883j/gingivitis
View source version on businesswire.com: http://www.businesswire.com/news/home/20170215005506/en/
[ Back To TMCnet.com's Homepage ]
|